Antonio Chamoun, MD
Interventional Cardiology · Thorndale, PANPI 1043281595
Payments from drug & device makers
Across 469 payments — averaging $39.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- Abbott$2K
- Abiomed$2K
- Shockwave Medical, Inc$2K
- Medtronic$648
- Johnson & Johnson$531
- plus $5K from 32 others
What the payments were for
- Speaking & faculty fees$4,00022%
- Travel & lodging$6614%
- Food & beverage$13,72074%
- Education$1531%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 102 | $6,775 |
| Abbott | 41 | $2,222 |
| Abiomed | 41 | $2,214 |
| Shockwave Medical, Inc | 63 | $1,533 |
| Medtronic(2 entities) | 28 | $648 |
| Johnson & Johnson | 20 | $531 |
| Amgen | 20 | $525 |
| AstraZeneca | 15 | $344 |
| Pfizer | 19 | $340 |
| Philips North America LLC | 11 | $319 |
| Impulse Dynamics (USA) Inc. | 8 | $286 |
| Cardiovascular Systems Inc. | 16 | $279 |
| E.r. Squibb & Sons, L.L.C. | 11 | $274 |
| Actelion Pharmaceuticals US, Inc. | 9 | $269 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $242 |
| Novartis | 12 | $217 |
| Cagent Vascular Inc | 2 | $209 |
| Edwards Lifesciences | 2 | $152 |
| Biotronik Inc. | 3 | $144 |
| Bard Peripheral Vascular, Inc. | 1 | $140 |
| Akcea Therapeutics, Inc. | 1 | $133 |
| Penumbra, Inc. | 5 | $119 |
| Heartflow, Inc. | 4 | $87 |
| Terumo Medical Corporation | 1 | $80 |
| Boehringer Ingelheim | 4 | $57 |
| W. L. Gore & Associates, Inc. | 3 | $56 |
| Amarin Pharma, Inc. | 2 | $46 |
| Atricure, Inc. | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| Cook Medical LLC | 2 | $34 |
| Sanofi-aventis U.S. LLC | 2 | $31 |
| Lexicon Pharmaceuticals, Inc. | 1 | $30 |
| Chiesi USA, Inc. | 2 | $27 |
| Teleflex LLC | 1 | $24 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Lantheus Medical Imaging, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $17 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$1,254
- Xience V coronary stent system$778
- AVVIGO Guidance System$425
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$285
- OPTIMIZER$218
- Serrantor$209
- SYMPLICITY G3$148
- Rotarex$140
- TEGSEDI$133
- ETERNA$128
- Repatha$125
- CAMZYOS$125
- CardioMEMS HF System$123
- FARXIGA$116
- GENERAL ATHERECTOMY$108
- XARELTO$106
- Edwards SAPIEN 3 Transcatheter Heart Valve$106
- GENERAL - STENTS$101
- MitraClip$101
How this compares
$18,534 in reported general payments places this provider in the 60th percentile of 281 interventional cardiology providers in Pennsylvania.
See all interventional cardiology providers in Pennsylvania →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Valsartan | 20 | $1,037 |
| Atorvastatin Calcium | 47 | $691 |
| Rosuvastatin Calcium | 47 | $638 |
| Metoprolol Succinate | 35 | $574 |
| Losartan Potassium | 42 | $498 |
| ClopidogrelClopidogrel Bisulfate | 36 | $448 |
| Carvedilol | 40 | $314 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 32 | $290 |
| Amlodipine Besylate | 35 | $270 |
| Hydrochlorothiazide | 30 | $150 |
| Lisinopril | 13 | $110 |
| Hydralazine Hcl | 19 | $68 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Thorndale
- William GrayWynnewood$3.3M
- Eric GnallWynnewood$2.4M
- Howard HerrmannPhiladelphia$2.2M
- Ramzi KhalilPittsburgh$1.6M
- Nishant SethiScranton$1.3M
- Matthew BeckerErie$1.3M
- David LasordaPittsburgh$1.1M
- Nainesh PatelAllentown$1.1M
- Jay GiriPhiladelphia$1M
- James HarveyChambersburg$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.